Health Trials

Congenital Antithrombin Deficiency

1

Review clinical trials related to Congenital Antithrombin Deficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

The goal of this study is to assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events (TEEs) in patients with congenital antithrombin deficiency under when they receive Atenativ for surgical procedures or parturition.

Participants needed: 38
Trial details
Phase: Phase 3Age: 12-80Biological sex: AllType: InterventionalSponsor: OctapharmaUpdated: Jun 3, 2026Locations: 30
Eligibility criteria

Adult male or female patients ≥18 and ≤80 years of age. Solely in the US, 4 male... [+5]

Requires emergency surgery or emergency caesarean section [+15]

Read more